Qingqing Wang
Hangzhou, 311121, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
ATP13A2 restrains macrophage NLRP3 inflammasome activation to repress neurodegeneration via modulating mitochondrial homeostasis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 17, 2026
Disrupting CSPG-Driven Microglia-Astrocyte Crosstalk Enables Scar-Free Repair in Spinal Cord Injury.
Disrupting CSPG-Driven Microglia-Astrocyte Crosstalk Enables Scar-Free Repair in Spinal Cord Injury.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 22, 2025
Alcaligenes faecalis induces intestinal T helper-17 cells by enhancing Rorc transcription through E3 ligase Trim21-mediated Fbxw7 degradation.
Journal: Immunity
Published: July 28, 2024
Transient autophagy inhibition strengthened postharvest tomato (Solanum lycopersicum) resistance against Botrytis cinerea through curtailing ROS-induced programmed cell death.
Journal: Food chemistry
Published: March 07, 2024
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance.
Journal: Cancers
Published: November 04, 2023
ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition.
Journal: Cell reports
Published: July 03, 2023
Huperzine A injection ameliorates motor and cognitive abnormalities via regulating multiple pathways in a murine model of Parkinson's disease.
Journal: European journal of pharmacology
Published: April 23, 2023
Epigenetic Regulation of IL-23 by E3 Ligase FBXW7 in Dendritic Cells Is Critical for Psoriasis-like Inflammation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 12, 2023
Enzymolysis-based RNA pull-down identifies YTHDC2 as an inhibitor of antiviral innate response.
Journal: Cell reports
Published: November 11, 2022
High-normal free thyroxine level is related with decreased bone mineral density in nonobese male patients with type 2 diabetes over 50 years old.
Journal: Therapeutic advances in chronic disease
Published: October 07, 2022
Last Updated: 09/26/2026